Drivers of Clinical Trial Participation-Demographics, Disparities, and Eligibility Criteria
JAMA Oncol
.
2019 Mar 1;5(3):305-306.
doi: 10.1001/jamaoncol.2018.5949.
Authors
Grace Mishkin
1
,
Fernanda Arnaldez
1
,
S Percy Ivy
1
Affiliation
1
Cancer Therapy Evaluation Program, Clinical Investigations and Investigational Drug Branches, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
PMID:
30629085
DOI:
10.1001/jamaoncol.2018.5949
No abstract available
Publication types
Comment
MeSH terms
Demography
Hispanic or Latino
Humans
Neoplasms*
White People*